Home Tags Aurobindo Pharma
Tag: Aurobindo Pharma
Agreement comprises the Sandoz US generic oral solids and Sandoz US dermatology businesses with approximately 300 products and H1 2018 sales of USD 0.6 billion. Transaction supports the Sandoz strategy of focusing on complex generics, value-added medicines and biosimilars...……..
Acquisition will extend and diversify Aurobindo’s European product portfolio by adding over 200 generics and more than 80 over-the-counter (OTC) products that had total sales of EUR 133 million in the year ending March 2018...…………..
In its recent annual report, the Aurobindo Pharma has revealed that it already has set up a huge manufacturing facility with 50 million dosage....